John Kao Sells 215,701 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Key Points

• CEO John Kao sold 215,701 shares of Alignment Healthcare on April 10 at an average price of $20.63 for about $4.45M, trimming his stake by 10.25% to 1,888,940 shares; the sale was made under a pre‑arranged Rule 10b5‑1 trading plan.
• The company beat quarterly expectations with revenue of $1.01B (up 44.4% YoY) and EPS of -$0.05 versus an expected -$0.15, but remains unprofitable with a negative net margin and a projected full‑year EPS of -$0.69.
• Analysts have been raising price targets (e.g., JPMorgan, TD Cowen, Piper Sandler), leaving a consensus rating of "Moderate Buy" and a consensus price target of $24.75.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 215,701 shares of the stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $20.63, for a total transaction of $4,449,911.63. Following the completion of the sale, the chief executive officer owned 1,888,940 shares of the company's stock, valued at approximately $38,968,832.20. This represents a 10.25% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Alignment Healthcare Stock Performance

NASDAQ ALHC traded up $0.48 during trading hours on Monday, reaching $20.98. 1,753,989 shares of the company were exchanged, compared to its average volume of 3,132,918. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The business's 50 day simple moving average is $19.29 and its 200-day simple moving average is $19.04. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.80. The stock has a market capitalization of $4.29 billion, a P/E ratio of -2,095.90, a P/E/G ratio of 3.00 and a beta of 1.20.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.15) by $0.10. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. During the same quarter last year, the company posted ($0.16) earnings per share. The firm's quarterly revenue was up 44.4% compared to the same quarter last year. On average, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Analysts Set New Price Targets

ALHC has been the subject of a number of research analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Alignment Healthcare from $23.00 to $26.00 and gave the stock an "overweight" rating in a report on Thursday, February 5th. TD Cowen raised their price objective on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a "buy" rating in a report on Friday, January 16th. Piper Sandler raised their price objective on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an "overweight" rating in a report on Tuesday, January 6th. Robert W. Baird set a $28.00 price objective on shares of Alignment Healthcare in a report on Friday, January 30th. Finally, UBS Group raised their price objective on shares of Alignment Healthcare from $18.00 to $21.00 and gave the stock a "neutral" rating in a report on Wednesday, January 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $24.75.

Hedge Funds Weigh In On Alignment Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Summit Securities Group LLC bought a new position in Alignment Healthcare during the fourth quarter worth about $26,000. Parallel Advisors LLC boosted its position in Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company's stock worth $33,000 after purchasing an additional 773 shares during the period. Larson Financial Group LLC bought a new position in Alignment Healthcare during the third quarter worth about $33,000. First Horizon Corp bought a new position in Alignment Healthcare during the fourth quarter worth about $39,000. Finally, GAMMA Investing LLC boosted its position in Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company's stock worth $43,000 after purchasing an additional 987 shares during the period. Institutional investors own 86.19% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.